Gvoke hypopen 2-PK 1 MG/0.2 ML 0.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY5X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,118
Award facts
- Contract value 100% obligated
- $2,117.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,117.88 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 mL) on January 8, 2026, with a completion date of January 9, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. GVOKE HypoPen is a glucagon emergency injection device used to treat severe hypoglycemia in diabetic patients, representing part of the company's broader medical supply portfolio supporting military healthcare systems.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., holds a significant $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical extending through December 2026, which serves as the vehicle enabling delivery of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The prime IDC encompasses a comprehensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's role as a critical pharmaceutical vendor fulfilling federal medical procurement requirements for the Department of Defense and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCY5X?
SPE2DR26FCY5X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FCY5X worth?
The government has obligated $2,118 on SPE2DR26FCY5X.
Is contract SPE2DR26FCY5X an order under another contract?
Yes. SPE2DR26FCY5X is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY5X competed?
The extent of competition for SPE2DR26FCY5X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award